IMV Technologies is the global leader in biotechnologies for animal artificial insemination.
Founded in 1963 and based in L’Aigle in the French region of Normandy, IMV Technologies is the global leader in biotechnologies for animal artificial insemination. Recognized worldwide for the quality of its products, the group’s development is based on the conception of new technologies and expertise for artificial insemination techniques. With five foreign subsidiaries (US, India, China, Italy and the Netherlands) and a network of distributors across more than 120 countries, IMV Technologies generates almost 80% of its revenue abroad and has around 450 employees.